In CRC tissues, aberrant glycosylation of MUC1 and other CRC antigens, such as carcinoembryonic antigen (CEA), can alter the mammalian lectin receptor interactions with tumor cells and could participate in immune modulation and immune evasion (Table 2) [81]. This evidence concerns the gene MUC1 and colorectal carcinoma.